Exact Sciences (EXAS) Tops Q2 EPS by 25c, provides guidance
Tweet
Share
E-mail
Get Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Sales and marketing: 26.31M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.09), $0.25 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $699.26 million versus the consensus estimate of $690.01 million.
GUIDANCE:
Exact Sciences sees FY2024 revenue of $2.81-2.85 billion, versus the consensus of $2.83 billion.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evogene (EVGN) Tops Q2 EPS by 15c
- iQIYI (IQ) Misses Q2 EPS by 21c
- H.C. Wainwright Reiterates Buy Rating on Invivyd Inc. (IVVD)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
